251 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
A Trip to 8-Year Bull Run: What's Up, What's Down http://www.zacks.com/stock/news/252331/a-trip-to-8-year-bull-run-whats-up-whats-down?cid=CS-ZC-FT-252331 Mar 09, 2017 - While all the three major indices more than tripled scaling multiple highs in recent months, Nasdaq has won the maximum in the eight-year bull run.
Incyte Corporation (INCY) Presents At Cowen and Company 37th Annual Health Care Conference http://seekingalpha.com/article/4053781-incyte-corporation-incy-presents-cowen-company-37th-annual-health-care-conference?source=feed_sector_healthcare Mar 09, 2017 - The following slide deck was published by Incyte Corporation in conjunction with this event.
5 Top Stocks to Buy as Bull Market Turns Eight http://www.zacks.com/stock/news/252252/5-top-stocks-to-buy-as-bull-market-turns-eight?cid=CS-ZC-FT-252252 Mar 09, 2017 - We have selected 5 Buy-ranked stocks that have outperformed in the current bull market with room to run higher.
5 Toxic Stocks to Dump or Play Short to Make Gains http://www.zacks.com/stock/news/252843/5-toxic-stocks-to-dump-or-play-short-to-make-gains?cid=CS-ZC-FT-252843 Mar 15, 2017 - Unreasonably high price of toxic stocks is only short-lived as the intrinsic value of these stocks is lower than the current bloated price.
Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data http://www.zacks.com/stock/news/252975/biotech-stock-roundup-amgens-data-on-repatha-catalyst-soars-on-firdapse-data?cid=CS-ZC-FT-252975 Mar 16, 2017 - The biotech sector reacted favorably to President Donald Trump's pick for the top post in the FDA.
Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback http://www.zacks.com/stock/news/256108/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback?cid=CS-ZC-FT-256108 Apr 12, 2017 - Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.
Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed http://www.zacks.com/stock/news/256797/biotech-stock-roundup-fda-crl-hits-incyte-pipeline-setbacks-weigh-on-oncomed?cid=CS-ZC-FT-256797 Apr 19, 2017 - Incyte's (INCY) shares were hit by the FDA's complete response letter (CRL) for the company's rheumatoid arthritis drug.
Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow https://seekingalpha.com/article/4075266-incyte-corporation-incy-presents-bank-america-merrill-lynch-2017-health-care-conference?source=feed_sector_healthcare May 22, 2017 - The following slide deck was published by Incyte Corporation in conjunction with this event.
Company News for May 19, 2017 http://www.zacks.com/stock/news/261262/company-news-for-may-19-2017?cid=CS-ZC--261262 May 19, 2017 - Companies in the News are: LB,P,INCY,MRK,SHPG
Incyte Corporation (INCY) Presents At Nasdaq 36th Investor Program - Slideshow https://seekingalpha.com/article/4082007-incyte-corporation-incy-presents-nasdaq-36th-investor-program-slideshow?source=feed_sector_healthcare Jun 16, 2017 - The following slide deck was published by Incyte Corporation in conjunction with this event.

Pages: 123456789...26

<<<Page 4>